Tech Company Financing Transactions
Verismo Therapeutics Funding Round
Verismo Therapeutics secured a $28 million financing round on 4/15/2026. Investors included HLB Co..
Transaction Overview
Company Name
Announced On
4/15/2026
Transaction Type
Venture Equity
Amount
$28,000,000
Round
Undisclosed
Investors
Proceeds Purpose
This funding ensures we have the resources to fully capitalize on that momentum -- advancing our solid tumor and blood cancer programs toward the data readouts that will define the potential for multi-chain KIR-CAR cell therapy to provide durable results over current single-chain CAR Ts.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
3675 Market St 200
Philadelphia, PA 19104
USA
Philadelphia, PA 19104
USA
Phone
Website
Email Address
Overview
Verismo Therapeutics is pioneering the development of novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer, especially non-hematologic malignancies with few effective therapeutic options.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Bryan Kim
Chief Operating Officer
Calvin Rhee
Co-Founder
Donald Siegel
Browse more venture capital transactions:
Prev: 4/15/2026: HealPort venture capital transaction
Next: 4/16/2026: Audrey AI venture capital transaction
Share this article
News on VC Transactions
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs